National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Understanding Cancer Series: Molecular Diagnostics
< Back to Main
In English     En español
    Posted: 01/28/2005    Reviewed: 09/01/2006
Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Slide 26  :  Molecular Diagnostics and Proteomics <  >  

Another major focus of molecular diagnostics looks beyond genes to an investigation of the proteome. The term "proteome" refers to all the proteins produced by a cell, and the study of these proteins is proteomics. Cancer proteomics is enabling mapping of the patterns of proteins involved when normal cellular pathways are hijacked in support of malignant growth. In cancerous tissue, some of the proteins critical for normal communication are damaged, inactive, overactive, or missing entirely. The full set of deranged and dominating proteins at work disrupting cellular communications may vary from one cancer type to another. They may also vary somewhat from one patient to another within a cancer type. 

Molecular Diagnostics and Proteomics

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov